🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with numerous of members share comparison photos, injection guides and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users administering products of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the service secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.

After moments of entering one group, a vendor shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages display black plastic parcels with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has already encountered individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to possibly serious health risks”.